Poxel S.A. (POXEL.PA)

EUR 0.38

(-4.88%)

Total Liabilities Summary of Poxel S.A.

  • Poxel S.A.'s latest annual total liabilities in 2023 was 53.9 Million EUR , up 1.79% from previous year.
  • Poxel S.A.'s latest quarterly total liabilities in 2023 FY was - EUR , down -100.0% from previous quarter.
  • Poxel S.A. reported annual total liabilities of 52.95 Million EUR in 2022, up 13.44% from previous year.
  • Poxel S.A. reported annual total liabilities of 46.68 Million EUR in 2021, up 22.21% from previous year.
  • Poxel S.A. reported quarterly total liabilities of - EUR for 2023 FY, down -100.0% from previous quarter.
  • Poxel S.A. reported quarterly total liabilities of 53.9 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Poxel S.A. (2023 - 2010)

Historical Annual Total Liabilities of Poxel S.A. (2023 - 2010)

Year Total Liabilities Total Liabilities Growth
2023 53.9 Million EUR 1.79%
2022 52.95 Million EUR 13.44%
2021 46.68 Million EUR 22.21%
2020 38.19 Million EUR 15.19%
2019 33.16 Million EUR -33.33%
2018 49.73 Million EUR 4.87%
2017 47.42 Million EUR 334.37%
2016 10.91 Million EUR 23.79%
2015 8.82 Million EUR -46.13%
2014 16.37 Million EUR -49.27%
2013 32.27 Million EUR 310.22%
2012 7.86 Million EUR 178.3%
2011 2.82 Million EUR 33.66%
2010 2.11 Million EUR 0.0%

Peer Total Liabilities Comparison of Poxel S.A.

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -679.818%
ABIVAX Société Anonyme 131.05 Million EUR 58.871%
Adocia SA 31.87 Million EUR -69.128%
Aelis Farma SA 13.08 Million EUR -312.087%
Biophytis S.A. 15.84 Million EUR -240.091%
Advicenne S.A. 24.37 Million EUR -121.114%
genOway Société anonyme 14.45 Million EUR -272.772%
IntegraGen SA 5.97 Million EUR -801.385%
Medesis Pharma S.A. 6.42 Million EUR -738.772%
Neovacs S.A. 3.71 Million EUR -1352.026%
NFL Biosciences SA 3.62 Million EUR -1388.697%
Plant Advanced Technologies SA 6.78 Million EUR -694.724%
Quantum Genomics Société Anonyme 3.31 Million EUR -1528.376%
Sensorion SA 13.22 Million EUR -307.499%
Theranexus Société Anonyme 5.01 Million EUR -974.541%
TME Pharma N.V. 2.78 Million EUR -1835.404%
Valbiotis SA 13.7 Million EUR -293.208%
TheraVet SA 1.48 Million EUR -3529.714%
Valerio Therapeutics Société anonyme 20.46 Million EUR -163.343%
DBV Technologies S.A. 38.74 Million USD -39.116%
Genfit S.A. 105.92 Million EUR 49.112%
GeNeuro SA 20.13 Million EUR -167.633%
Innate Pharma S.A. 132.29 Million EUR 59.256%
Inventiva S.A. 101.59 Million EUR 46.944%
MaaT Pharma SA 22.46 Million EUR -139.933%
MedinCell S.A. 77.77 Million EUR 30.692%
Nanobiotix S.A. 95.74 Million EUR 43.701%
OSE Immunotherapeutics SA 59.07 Million EUR 8.765%
GenSight Biologics S.A. 34.72 Million EUR -55.214%
Transgene SA 26.51 Million EUR -103.27%
Valneva SE 341.14 Million EUR 84.2%